erythromycin has been researched along with Bleb in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cooper, SM; Powell, J; Wojnarowska, F | 1 |
| Andrews, JM; Cooper, MA; Nye, K; Wise, R | 1 |
| Haataja, H; Männistö, PT; Pohto, P; Solkinen, A; Tuominen, RK; Vuorela, A | 1 |
| Audurier, A; Lorette, G; Loulergue, J; Vaillant, L | 1 |
| Nguyen, P; Pibouin, M; Renouard, A; Tillement, JP; Zini, R | 1 |
1 trial(s) available for erythromycin and Bleb
| Article | Year |
|---|---|
Antibiotic concentration in suction skin blister fluid and saliva after repeated dosage of erythromycin acistrate and erythromycin base.
Topics: Adult; Blister; Erythromycin; Female; Humans; Hydrolysis; Male; Orosomucoid; Random Allocation; Saliva; Suction | 1988 |
4 other study(ies) available for erythromycin and Bleb
| Article | Year |
|---|---|
Linear IgA disease: successful treatment with erythromycin.
Topics: Anti-Bacterial Agents; Autoimmune Diseases; Blister; Erythromycin; Female; Humans; Immunoglobulin A; Infant; Male; Middle Aged; Skin Diseases, Vesiculobullous | 2002 |
The pharmacokinetics and inflammatory fluid penetration of orally administered azithromycin.
Topics: Administration, Oral; Adult; Azithromycin; Blister; Erythromycin; Exudates and Transudates; Half-Life; Humans; Male | 1990 |
Erythromycin ethyl succinate: diffusion through interstitial dermal fluid.
Topics: Adult; Aged; Blister; Diffusion; Erythromycin; Erythromycin Ethylsuccinate; Extracellular Space; Female; Humans; Male; Middle Aged; Skin | 1987 |
Binding of 8-methoxypsoralen to human serum proteins and red blood cells.
Topics: Binding Sites; Blister; Blood Proteins; Diazepam; Erythrocytes; Erythromycin; Humans; Indomethacin; Methoxsalen; Protein Binding; Salicylates; Salicylic Acid; Warfarin | 1987 |